Vascular News and Research

RSS

Clovis Oncology reports net loss of $30.7 million for first quarter 2014

Clovis Oncology, Inc. reported financial results for its first quarter ended March 31, 2014, and provided an update on the Company's clinical development programs for the rest of 2014.

9 May 2014

CT-guided IRE therapy offers safe, feasible primary local treatment for advanced pancreatic cancer

A small group of patients with locally advanced unresectable pancreatic carcinoma suffered no major ill effects-pancreatitis or fistula formation-after undergoing percutaneous CT-guided irreversible electroporation (IRE)-a nonthermal ablation technology that is safe near vascular and ductal structures-as a therapy.

8 May 2014

Patients undergoing peritoneal dialysis catheter placement experience fewer complications

Patients undergoing peritoneal dialysis catheter placement via fluoroscopy and ultrasound-guidance experienced significantly fewer complications at 1 year post-insertion than did patients whose catheters were placed laparoscopically.

8 May 2014

Lifestyle intervention for impaired glucose tolerance wards off vascular mortality

Implementing lifestyle changes in patients with impaired glucose tolerance has lasting cardiovascular benefits, show findings published in The Lancet Diabetes and Endocrinology.

7 May 2014

Triple therapy shows promise for severe PAH

Results of a small pilot study among patients with severe pulmonary arterial hypertension support the long-term benefits of upfront triple combination therapy, French researchers report.

7 May 2014

Covidien opens new facility in Turkey to expand training and research capabilities

Further expanding its training and research capabilities in emerging markets, Covidien plc (NYSE: COV), has officially opened its Covidien Center of Innovation Turkey (CCI Turkey).

7 May 2014

IKKβ links vascular inflammation to obesity and atherosclerosis development

A study in The Journal of Experimental Medicine shows that IκB kinase β (IKKβ) functions in smooth muscle cells to regulate vascular inflammatory responses and atherosclerosis development.

7 May 2014

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals, Inc. today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013.

6 May 2014

Concise analysis of global disposable gloves market

MRRBIZ includes new market research report "Disposable Gloves Market For Medical and Non-Medical (Food, Cleanroom, Industrial And Other) Applications - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019" to its large collection of research report.

6 May 2014

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Tufts University today announced that it has licensed a novel silk technology for the treatment of chronic skin wounds to Akeso Biomedical, Inc., an early stage medical device company.

6 May 2014

Study shows room for improvement in medical management of women with PAD

Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral artery disease (PAD), but minimally invasive procedures used to unclog arteries are just as successful as in men.

6 May 2014

Phosphate linked to cause high blood pressure and heart disease

Researchers find link between phosphate rich foods and an enzyme linked to cardiovascular disease. The findings also link phosphates to renal disease.

6 May 2014

Scientists develop bone marrow-on-a-chip to test effects of new drugs, toxic agents on bone marrow

The latest organ-on-a-chip from Harvard's Wyss Institute for Biologically Inspired Engineering reproduces the structure, functions and cellular make-up of bone marrow, a complex tissue that until now could only be studied intact in living animals, Institute researchers report in the May 4, 2014, online issue of Nature Methods.

6 May 2014

Traditional first-line checks not good enough to identify cardiovascular disease in young firefighters

Traditional first-line checks of such heart disease risk factors as cholesterol, blood pressure and smoking habits aren’t nearly good enough to identify cardiovascular disease in otherwise healthy, young firefighters, according to results of a small Johns Hopkins study.

2 May 2014

Study investigates how nanoparticles could be used to improve diagnosis, treatment of cardiovascular disease

A study to investigate how nanoparticles could be used to improve the diagnosis and treatment of cardiovascular disease has received -3 million funding.

2 May 2014

Scientists develop experimental drug that prolongs lifespan in mouse model of accelerated aging

Northwestern Medicine- scientists have newly identified a protein's key role in cell and physiological aging and have developed - in collaboration with Tohoku University in Japan -- an experimental drug that inhibits the protein's effect and prolonged the lifespan in a mouse model of accelerated aging.

2 May 2014

Noninvasive technique detects prostate cancer using an electronic nose

We may soon be able to make easy and early diagnoses of prostate cancer by smell. Investigators in Finland have established that a novel noninvasive technique can detect prostate cancer using an electronic nose. In a proof of principle study, the eNose successfully discriminated between prostate cancer and benign prostatic hyperplasia (BPH) by "sniffing" urine headspace (the space directly above the urine sample). Results using the eNose are comparable to testing prostate specific antigen (PSA), reports the Journal of Urology.

1 May 2014

Imaging technique may help understanding of chronic CSCR

Swept-source optical coherence tomography identifies the morphological features implicated in the underlying physiopathological mechanisms of chronic central serous chorioretinopathy, researchers report.

1 May 2014

Ranibizumab trial gets promising results for CNV

Patients with visual impairment due to myopic choroidal neovascularisation achieve better visual acuity after 3 months of individualised treatment with ranibizumab than with verteporfin photodynamic therapy, show the results of a phase III randomised controlled trial.

1 May 2014

DJOFL first quarter 2014 net sales increase 1.3% to $282.7 million

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its public reporting subsidiary, DJO Finance LLC, for the first quarter ended March 29, 2014.

29 Apr 2014

Vascular News and Research

Clovis Oncology reports net loss of $30.7 million for first quarter 2014

CT-guided IRE therapy offers safe, feasible primary local treatment for advanced pancreatic cancer

Patients undergoing peritoneal dialysis catheter placement experience fewer complications

Lifestyle intervention for impaired glucose tolerance wards off vascular mortality

Triple therapy shows promise for severe PAH

Covidien opens new facility in Turkey to expand training and research capabilities

IKKβ links vascular inflammation to obesity and atherosclerosis development

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Concise analysis of global disposable gloves market

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Study shows room for improvement in medical management of women with PAD

Phosphate linked to cause high blood pressure and heart disease

Scientists develop bone marrow-on-a-chip to test effects of new drugs, toxic agents on bone marrow

Traditional first-line checks not good enough to identify cardiovascular disease in young firefighters

Study investigates how nanoparticles could be used to improve diagnosis, treatment of cardiovascular disease

Scientists develop experimental drug that prolongs lifespan in mouse model of accelerated aging

Noninvasive technique detects prostate cancer using an electronic nose

Imaging technique may help understanding of chronic CSCR

Ranibizumab trial gets promising results for CNV

DJOFL first quarter 2014 net sales increase 1.3% to $282.7 million

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News